Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Ágnes Csuth, Maria Christina Jenmalm, Lene Heise Garvey
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Safe de-labeling of patients at low risk of penicillin allergy in Denmark
10.1159/000521708 · 2022
Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital
10.1093/jac/dky575 · 2019
Penicillin allergy delabeling has a significant impact on subsequent antibiotic use in primary care
10.1016/j.waojou.2024.100958 · 2024
De-labelling penicillin allergy in acutely hospitalized patients: a pilot study
10.1186/s12879-021-06794-1 · 2021
Delabeling of penicillin allergy: room for improvement
10.1159/000530770 · 2023
Self-reported drug allergy in a general adult Portuguese population
10.1111/j.1365-2222.2004.02070.x · 2004
Frequency of self-reported drug allergy: a systematic review and meta-analysis with meta-regression
10.1016/j.anai.2017.07.009 · 2017
The impact of penicillin allergy labels on antibiotic and health care use in primary care: a retrospective cohort study
10.1186/s13601-017-0154-y · 2017
Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study
10.1016/j.jaci.2013.09.021 · 2014
The impact of a reported penicillin allergy on surgical site infection risk
10.1093/cid/cix794 · 2018
Association between penicillin allergy labels and serious adverse events in hospitalized patients: a systematic review and meta-analysis
10.3389/fphar.2024.1519522 · 2025
Changing patterns in the epidemiology of drug allergy
10.1111/all.15970 · 2024
Antibiotic use in Australian and Swedish primary care: a cross-country comparison
10.1080/02813432.2022.2036494 · 2022
Exploring the One Health perspective in Sweden’s policies for containing antibiotic resistance
10.3390/antibiotics10050526 · 2021
Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance
10.2471/blt.16.184374 · 2017
Negative impact of penicillin allergy labels on antibiotic use in hospitalized patients in Chinese mainland
10.1016/j.waojou.2022.100677 · 2022
De-labelling penicillin allergy in acutely hospitalized patients: a pilot study
10.1186/s12879-021-06794-1 · 2021
Assessing the prevalence and characteristics of self-reported penicillin allergy in Saudi Arabian population: a nationwide cross-sectional study
10.1016/j.jsps.2022.12.006 · 2023
Higher risk of revision for infection using systemic clindamycin prophylaxis than with cloxacillin
10.1080/17453674.2017.1324677 · 2017
Trends in antibiotic use in Danish, Finnish, Norwegian and Swedish children
10.2147/clep.s362262 · 2022
Measuring hospital antibiotic consumption in EU/EEA countries: comparison of different metrics, 2017 to 2021
10.2807/1560-7917.es.2024.29.46.2400317 · 2024
EAACI/ENDA position paper on drug provocation testing
10.1111/all.15996 · 2024
Drug allergy: a 2022 practice parameter update
10.1016/j.jaci.2022.08.028 · 2022
Prevalence and characteristics of reported penicillin allergy in an urban outpatient adult population
10.2500/aap.2014.35.3791 · 2014
European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe
10.1093/jac/dkl186 · 2006
Effectiveness of interventions that support penicillin allergy assessment and de-labeling of patients by non-allergy specialists: a systematic review protocol
10.11124/jbies-21-00075 · 2022
Implementation of a pharmacist-led outpatient penicillin allergy testing clinic
10.1016/j.japh.2025.102346 · 2025
No additional external references are available.